SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/17/14 Biolase, Inc 10-K 12/31/13 76:14M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.28M 2: EX-4 Ex-4.4 HTML 29K 3: EX-10 Ex-10.42 HTML 61K 4: EX-21 Ex-21.1 HTML 21K 5: EX-23 Ex-23.1 HTML 23K 6: EX-31 Ex-31.1 HTML 29K 7: EX-31 Ex-31.2 HTML 29K 8: EX-32 Ex-32.1 HTML 25K 9: EX-32 Ex-32.2 HTML 25K 53: R1 Document and Entity Information HTML 53K 43: R2 Consolidated Balance Sheets HTML 144K 51: R3 Consolidated Balance Sheets (Parenthetical) HTML 51K 55: R4 Consolidated Statements Of Operations And HTML 107K Comprehensive Loss 71: R5 Consolidated Statements Of Shareholders' Equity HTML 101K (Deficit) 45: R6 Consolidated Statements Of Cash Flows HTML 176K 50: R7 Basis of Presentation HTML 55K 39: R8 Summary of Significant Accounting Policies HTML 152K 30: R9 Supplementary Balance Sheet Information HTML 122K 72: R10 Intangible Assets and Goodwill HTML 92K 57: R11 Lines of Credit and Other Borrowings HTML 44K 56: R12 Income Taxes HTML 190K 62: R13 Commitments and Contingencies HTML 56K 63: R14 Stockholders' Equity HTML 274K 61: R15 Segment Information HTML 49K 64: R16 Concentrations HTML 26K 52: R17 Subsequent Events HTML 38K 54: R18 Schedule II-Consolidated Valuation and Qualifying HTML 88K Accounts and Reserves 60: R19 Accounting Policies (Policies) HTML 306K 76: R20 Summary of Significant Accounting Policies HTML 109K (Tables) 67: R21 Supplementary Balance Sheet Information (Tables) HTML 129K 47: R22 Intangible Assets and Goodwill (Tables) HTML 83K 58: R23 Income Taxes (Tables) HTML 183K 49: R24 Commitments and Contingencies (Tables) HTML 31K 24: R25 Stockholders' Equity (Tables) HTML 229K 68: R26 Segment Information (Tables) HTML 41K 73: R27 Basis of Presentation - Additional Information HTML 52K (Detail) 34: R28 Estimated Useful Lives of Property, Plant and HTML 28K Equipment (Detail) 33: R29 Changes in Initial Product Warranty Accrual and HTML 41K Expenses Under Initial and Extended Warranties (Detail) 37: R30 Classification of Compensation Expense Associated HTML 32K with Share-Based Payments (Detail) 38: R31 Assumptions Used in Estimating Fair Value of Stock HTML 35K Options Granted (Detail) 40: R32 Summary of Significant Accounting Policies - HTML 57K Additional Information (Detail) 22: R33 Components of Accounts Receivable, Net of HTML 31K Allowance (Detail) 65: R34 Components of Inventory (Detail) HTML 34K 46: R35 Summary of Property, Plant, and Equipment (Detail) HTML 45K 48: R36 Components of Accrued Liabilities (Detail) HTML 51K 27: R37 Summary of Deferred Revenue (Detail) HTML 40K 75: R38 Supplementary Balance Sheet Information - HTML 48K Additional Information (Detail) 16: R39 Intangible Assets and Related Accumulated HTML 56K Amortization (Detail) 41: R40 Intangible Assets and Goodwill - Additional HTML 44K Information (Detail) 70: R41 Lines of Credit and Other Borrowings - Additional HTML 137K Information (Detail) 26: R42 Summary of Income Tax Current and Deferred HTML 69K Provision (Benefit) (Detail) 32: R43 Federal Income Tax Provision Compared With HTML 63K Statutory Rates (Detail) 36: R44 Summary of Net Deferred Tax Assets and Net HTML 87K Deferred Tax Liabilities (Detail) 44: R45 Summary of Unrecognized Tax Benefits (Detail) HTML 31K 21: R46 Income Taxes - Additional Information (Detail) HTML 58K 29: R47 Commitments and Contingencies - Additional HTML 41K Information (Detail) 18: R48 Future Minimum Rental Commitments Under Operating HTML 45K Lease Agreements (Detail) 69: R49 Summary of Option Activity (Detail) HTML 81K 25: R50 Options Outstanding and Exercisable (Detail) HTML 70K 66: R51 Cash Proceeds Along with Fair Value Disclosures HTML 41K Related to Grants Exercises and Vesting Options (Detail) 28: R52 Stockholders' Equity - Additional Information HTML 251K (Detail) 42: R53 Summary of Net Revenue by Geographic Location HTML 27K (Detail) 17: R54 Segment Information - Additional Information HTML 32K (Detail) 20: R55 Concentrations - Additional Information (Detail) HTML 36K 35: R56 Subsequent Events - Additional Information HTML 67K (Detail) 23: R57 Consolidated Valuation and Qualifying Accounts and HTML 36K Reserves (Detail) 74: XML IDEA XML File -- Filing Summary XML 111K 19: EXCEL IDEA Workbook of Financial Reports XLSX 190K 31: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.05M 10: EX-101.INS XBRL Instance -- biol-20131231 XML 2.69M 12: EX-101.CAL XBRL Calculations -- biol-20131231_cal XML 200K 13: EX-101.DEF XBRL Definitions -- biol-20131231_def XML 1.08M 14: EX-101.LAB XBRL Labels -- biol-20131231_lab XML 1.53M 15: EX-101.PRE XBRL Presentations -- biol-20131231_pre XML 1.21M 11: EX-101.SCH XBRL Schema -- biol-20131231 XSD 220K 59: ZIP XBRL Zipped Folder -- 0001564590-14-000856-xbrl Zip 215K
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Federico Pignatelli, certify that:
1. I have reviewed this Annual Report on Form 10-K of BIOLASE, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s fourth fiscal quarter ended December 31, 2013 that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize, and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: March 17, 2014 |
||
|
|
|
By: |
|
|
|
|
|
|
|
Chief Executive Officer |
|
|
(Principal Executive Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/17/14 | 8-K/A, DEFA14A | ||
For Period end: | 12/31/13 | 10-K/A, SD | ||
List all Filings |